Unknown
Who we are
Fc-Engineered Anti-CTLA-4 Monoclonal Antibody Botensilimab in Advanced Cancer
Evaluation for NCI Surgery Branch Immunotherapy Clinical Research Protocols
Neo-T in Treating Patients With Advanced Solid Tumors(GI-NeoT-03)
A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer Without Liver Metastases
Botensilimab, Balstilimab and Regorafenib for the Treatment of Patients With Microsatellite Stable Metastatic Colorectal Cancer Who Have Progressed on Prior Chemotherapy
Pembrolizumab and Disitamab Vedotin in HER2-expressing Metastatic Colorectal Cancer
Personalized TCR-T: Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T)
Evaluating Novel Therapies in ctDNA Positive GI Cancers
Disitamab Vedotin Combined With Tislelizumab in Advanced HER2 Positive Colorectal Cancer
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
